| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |